| Title |
Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, June 2012
|
| DOI | 10.1007/s00228-012-1313-7 |
| Pubmed ID | |
| Authors |
Linda Härmark, Eugène van Puijenbroek, Kees van Grootheest |
| Abstract |
Duloxetine (Cymbalta(®)) is a serotonin (5-HT) and norepinephrine (NE) re-uptake inhibitor indicated for the treatment of depression, diabetic peripheral neuropathic pain and general anxiety disorder. The aim of this study is to gain insight in the user and safety profile of duloxetine in daily practice, reported by patients via a web-based intensive monitoring system during their first 6 months of use. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| Portugal | 1 | <1% |
| Norway | 1 | <1% |
| Unknown | 107 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 25% |
| Researcher | 18 | 16% |
| Student > Ph. D. Student | 17 | 15% |
| Other | 8 | 7% |
| Student > Doctoral Student | 7 | 6% |
| Other | 16 | 15% |
| Unknown | 17 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 30% |
| Psychology | 15 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Nursing and Health Professions | 5 | 5% |
| Agricultural and Biological Sciences | 5 | 5% |
| Other | 21 | 19% |
| Unknown | 24 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2014.
All research outputs
#3,244,080
of 22,723,682 outputs
Outputs from European Journal of Clinical Pharmacology
#266
of 2,552 outputs
Outputs of similar age
#22,428
of 167,203 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#4
of 31 outputs
Altmetric has tracked 22,723,682 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,552 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,203 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.